RE targets can swell solar import bill to $30 billion a year

India’s renewable energy RE) ambitions could increase the country’s annual solar import bill to $ 30 billion from $ 7 billion currently with most of it coming from China and as the entire world faces the same issue in its efforts to decarbonise key countries need to unite to global scale solar manufacturing facilities, according to a report by Global Trade Research Initiative.

To meet its goal of 500 GW of renewable energy by 2030 India needs to add 65 to 70 GW each year. This target is ambitious considering that 15 GW of solar capacity in 2023-24 and the US plans to add 32 GW in 2024.

For the solar capacity addition last financial year India imported $ 7 billion worth of solar equipment with China supplying 62.6% of it. China controls 97% of global polysilicon and 80% of solar module manufacturing making it difficult for any country to compete due to lower prices from China. Complete dominance by China that keeps the market oversupplied, putting pressure on manufacturing efforts of countries like India and US. 

Also Read Haryana’s new BJP government set to take oath on October 17, PM Modi to attend ceremony AAI, Madhya Pradesh govt sign MoU to expand Shivpuri Airport, aims to transform it into ‘key regional hub’ AMPIN Energy aims to add 25 GW of RE capacity by 2030 10-year g-sec yield slumps to 32-month low

“The US, India, EU and Japan may unite to establish global scale solar-cell manufacturing facilities. While it may be costly initially, it is essential to break free from China’s dominance,” GGTRI co-founder and author of the report ‘Global Solar Industry in China’s Iron Grip’ Ajay Srivastava said

While initiatives like the Production Linked Incentive (PLI) scheme aim to boost local manufacturing, its impact is limited as it relies on imported inputs. Around 90% of solar manufacturing in India involves assembling solar modules from solar cells with 15% value addition. Very few Indian companies produce commercial scale solar cells from imported polysilicon or wafers that adds 30-40% value locally.

Developing a self-reliant solar manufacturing industry in India will require significant investment to create an integrated supply chain especially in areas like polysilicon and wafer production. Without it India may continue to face high import costs and struggle to meet its renewable energy goals.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth